BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 17175403)

  • 1. Access to treatment-related and support services in methadone treatment programs.
    Berkman ND; Wechsberg WM
    J Subst Abuse Treat; 2007 Jan; 32(1):97-104. PubMed ID: 17175403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comprehensive care of drug addiction during a 5-year period at the methadone center in Prague].
    Popov P; Becka J; Wilczek H
    Vnitr Lek; 2003 Nov; 49(11):851-8. PubMed ID: 14689681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
    Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
    Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
    Whitley SD; Kunins HV; Arnsten JH; Gourevitch MN
    J Subst Abuse Treat; 2007 Jul; 33(1):85-90. PubMed ID: 17588493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepine prescription for patients in opioid maintenance treatment in Norway.
    Bramness JG; Kornør H
    Drug Alcohol Depend; 2007 Oct; 90(2-3):203-9. PubMed ID: 17478058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians practicing in methadone treatment programs: who are they and what do they do?
    Wechsberg WM; Flannery B; Kasten JJ; Suerken C; Dunlap L; Roussel AE; Crum L; Murdoch O; Diesenhaus H
    J Addict Dis; 2004; 23(2):15-31. PubMed ID: 15132340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-site medical care in methadone maintenance: associations with health care use and expenditures.
    Gourevitch MN; Chatterji P; Deb N; Schoenbaum EE; Turner BJ
    J Subst Abuse Treat; 2007 Mar; 32(2):143-51. PubMed ID: 17306723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methadone, maintenance program and reduction of drug abuse. An expanding practice].
    Tremblay M
    Perspect Infirm; 2005; 2(3):40-1. PubMed ID: 15686211
    [No Abstract]   [Full Text] [Related]  

  • 11. Sociodemographic disparities in supplemental service utilization among male methadone patients.
    Wu E; El-Bassel N; Gilbert L; Piff J; Sanders G
    J Subst Abuse Treat; 2004 Apr; 26(3):197-202. PubMed ID: 15063913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of opiate-dependent adolescents in the Vaud canton. Reflections on the indication for treatment with methadone].
    Savoy J; Laget J; Charpentier P; Sanchez-Mazas P; Besson J; Halfon O
    Rev Med Suisse Romande; 1999 Nov; 119(11):943-50. PubMed ID: 10628219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge of and interest in hepatitis C treatment at a methadone clinic.
    Walley AY; White MC; Kushel MB; Song YS; Tulsky JP
    J Subst Abuse Treat; 2005 Mar; 28(2):181-7. PubMed ID: 15780548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
    King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
    J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
    Watson B; Conigrave KM; Wallace C; Whitfield JB; Wurst F; Haber PS
    Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment.
    King VL; Burke C; Stoller KB; Neufeld KJ; Peirce J; Kolodner K; Kidorf M; Brooner RK
    J Subst Abuse Treat; 2008 Oct; 35(3):312-21. PubMed ID: 18294805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tighten Ontario's methadone program states inquest.
    Sibbald B
    CMAJ; 2005 Feb; 172(3):319-20. PubMed ID: 15684108
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinic-based treatment for opioid dependence: a qualitative inquiry.
    McMurphy S; Shea J; Switzer J; Turner BJ
    Am J Health Behav; 2006; 30(5):544-54. PubMed ID: 16893317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Social competence evaluated by patients on methadone maintenance treatment program].
    Szczepańskai L; Chrostek Maj J; Jenner B
    Przegl Lek; 2005; 62(6):382-6. PubMed ID: 16225074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.